Serum glial fibrillary acidic protein as a marker of brain MRI metrics in multiple sclerosis: A scoping review.
Noah MariniNikolai LesackSama AlizadehAliya KaniVanessa KitchinIrene M VavasourCornelia LaulePublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2024)
These results highlight that while sGFAP may not be specific for MS, it may have utility for increasing sensitivity in postdiagnosis monitoring of MS progression.